Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 2 - ARBITER 2

Description:

ARBITER-2 was a randomized, double-blind, single-center secondary prevention trial of extended-release niacin versus placebo in patients with controlled low-density lipoprotein (LDL) cholesterol levels already taking statin therapy.